Trial Profile
Phase II Study of TRK-820 Soft Capsules — Intractable Pruritus in Patients With Chronic Liver Disease
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 26 Mar 2022
Price :
$35
*
At a glance
- Drugs Nalfurafine (Primary)
- Indications Pruritus
- Focus Therapeutic Use
- Sponsors Toray
- 17 Jun 2014 New trial record